Where are they now: PolyNovo
PolyNovo’s NovoSorb® technology has redefined burn and wound care worldwide - emerging from a Melbourne lab into a global med-tech powerhouse backed by CSIRO.
Read morePolyNovo’s NovoSorb® technology has redefined burn and wound care worldwide - emerging from a Melbourne lab into a global med-tech powerhouse backed by CSIRO.
Read moreAustralia’s AMA endorses the Declaration of Helsinki, reinforcing its commitment to ethical research. Here’s why participant protection is vital for progress.
Read moreAustralia’s public hospital system is facing critical pressure. The AMA proposes a $27.8B plan to reverse worsening delays, overcrowding, and burnout.
Read moreAs NDIS fraud escalates, healthcare professionals can play a vital role in early detection and prevention. Here’s how GPs can support patients at risk.
Read moreWith record RSV cases in infants, Australia’s dual immunisation strategy offers real hope. Learn how maternal vaccination and infant antibodies can prevent RSV hospitalisation.
Read moreThe Albanese Government’s $8.5B Medicare plan expands bulk-billing incentives and aims to boost GP access while raising questions about viability for practices.
Read moreChronic kidney disease often progresses silently. Early detection through risk-based screening in primary care can improve outcomes and reduce the burden of ESKD.
Read moreThe DRAW program integrates cultural knowledge, shared medical visits, and real-time glucose monitoring to help First Nations women manage and even reverse T2DM.
Read moreWhile most recover fully from COVID-19, some experience lasting lung damage. Explore the latest research on post-COVID fibrosis, treatment, and transplantation.
Read moreJoin the Hamilton Island GP Conference 2025 for expert-led CPD education in a stunning tropical setting. Learn, unwind, and connect with fellow practitioners.
Read more